AURKB and prostate carcinoma: After growth arrest and polyploidy, AURKB inhibition triggers cell death in lung cancer, leukemia, prostate cancer, or neuroblastoma cell40,42,43 but senescence in fibroblasts, endothelial or melanoma cells41,44.